微博
加入微博一起分享新鲜事
登录
|
注册
140
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma https://www.theragnostics.no/publications/l%C3%B8ndalen-2021-fdg/
请登录并选择要私信的好友
300
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma https://www.theragnostics.no/publications/l%C3%B8ndalen-2021-fdg/
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候